HUP0203477A2 - Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaik - Google Patents
Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaikInfo
- Publication number
- HUP0203477A2 HUP0203477A2 HU0203477A HUP0203477A HUP0203477A2 HU P0203477 A2 HUP0203477 A2 HU P0203477A2 HU 0203477 A HU0203477 A HU 0203477A HU P0203477 A HUP0203477 A HU P0203477A HU P0203477 A2 HUP0203477 A2 HU P0203477A2
- Authority
- HU
- Hungary
- Prior art keywords
- heteroalkyl
- heterosubstituted
- cycloalkyl
- alkyl
- inhibitors
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229910052757 nitrogen Inorganic materials 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005356 cycloalkylalkenyl group Chemical group 0.000 abstract 2
- 125000005357 cycloalkylalkynyl group Chemical group 0.000 abstract 2
- 125000004404 heteroalkyl group Chemical group 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 239000012826 P38 inhibitor Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005343 heterocyclic alkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Az (I) általános képletű alkil-amino- helyettesített dihidro-pirimido[4,5-d]pirimidinon-származékok[mely képletben n értéke 0-3;R1 jelentése hidrogénatom, alkil-, alkenil-, alkinil-, alkil-karbonil-; cikloalkil-, cikloalkenil-, cikloalkil-alkil-, cikloalkil-alkenil-, cikloalkil-alkinil- vagy aralkil-csoport; R2 jelentéseegymástól függetlenül alkilcsoport, halogénatom, heteroalkil- vagyvinilcsoport; és R3 jelentése heteroalkil-, heteroalkenil-,heteroalkinil-, heteroalkil-karbonil-, heterohelyettesítettcikloalkil-, heterohelyettesített ciklo<- >alkil-alkil-,heterohelyettesített cikloalkil-alkenil-, heterohelyet<- >tesítettcikloalkil-alkinil-, heteroalkil-helyettesített cikloalkil-,heterociklikus-, heterociklikus-alkil-, aril-heteroalkil-, heteroaril-heteroalkil-, -(alkilén)-C(O)R31 vagy -(heteroalkilén)-C(O)R31csoport; ahol R31 jelentése alkil-, halogén-alkil-, hidroxi-, alkoxi-,amino-, egyszeresen vagy kétszeresen helyettesített amino-,cikloalkil-, cikloalkil-alkil-, aril-, aralkil-, heteroaril- vagyheteroaralkil-csoport] és gyógyászatilag alkalmas sóik értékes p38inhibitorok. Találmányunk az új vegyületekre, előállításukra és avegyületeket tartalmazó gyógyászati készítményekre vonatkozik. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16080499P | 1999-10-21 | 1999-10-21 | |
US21371800P | 2000-06-22 | 2000-06-22 | |
PCT/EP2000/010077 WO2001029041A1 (en) | 1999-10-21 | 2000-10-13 | Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0203477A2 true HUP0203477A2 (hu) | 2003-01-28 |
HUP0203477A3 HUP0203477A3 (en) | 2004-12-28 |
Family
ID=26857242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0203477A HUP0203477A3 (en) | 1999-10-21 | 2000-10-13 | Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase, pharmaceutical compositions containing them and their preparations |
Country Status (25)
Country | Link |
---|---|
US (1) | US6642241B1 (hu) |
EP (1) | EP1226144B1 (hu) |
KR (1) | KR100537241B1 (hu) |
CN (1) | CN1156477C (hu) |
AR (1) | AR026187A1 (hu) |
AT (1) | ATE349447T1 (hu) |
AU (1) | AU776695B2 (hu) |
BR (1) | BR0014973A (hu) |
CA (1) | CA2388140C (hu) |
CO (1) | CO5251408A1 (hu) |
CZ (1) | CZ20021743A3 (hu) |
DE (1) | DE60032623T2 (hu) |
ES (1) | ES2277858T3 (hu) |
HK (1) | HK1051040A1 (hu) |
HR (1) | HRP20020327A2 (hu) |
HU (1) | HUP0203477A3 (hu) |
IL (1) | IL149230A0 (hu) |
MA (1) | MA26836A1 (hu) |
MX (1) | MXPA02003841A (hu) |
NO (1) | NO20021783L (hu) |
PE (1) | PE20010760A1 (hu) |
PL (1) | PL357494A1 (hu) |
TR (1) | TR200201058T2 (hu) |
WO (1) | WO2001029041A1 (hu) |
YU (1) | YU29202A (hu) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040044012A1 (en) * | 1998-05-26 | 2004-03-04 | Dobrusin Ellen Myra | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
DE69939168D1 (de) | 1998-05-26 | 2008-09-04 | Warner Lambert Co | Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung |
AU2003225072A1 (en) * | 2002-04-19 | 2003-11-03 | Smithkline Beecham Corporation | Novel compounds |
CA2492033A1 (en) | 2002-07-09 | 2004-01-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
US7196090B2 (en) | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
KR100793688B1 (ko) * | 2002-08-06 | 2008-01-10 | 에프. 호프만-라 로슈 아게 | P-38 미토겐 활성 단백질 키나제 억제제로서6-알콕시-피리도-피리미딘 |
EP1539755B1 (en) * | 2002-08-06 | 2007-09-26 | F. Hoffmann-La Roche Ag | 6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors |
US7084270B2 (en) * | 2002-08-14 | 2006-08-01 | Hoffman-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
US7129351B2 (en) | 2002-11-04 | 2006-10-31 | Hoffmann-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
TW200413381A (en) | 2002-11-04 | 2004-08-01 | Hoffmann La Roche | Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
MXPA05010765A (es) | 2003-04-10 | 2005-12-12 | Hoffmann La Roche | Compuestos pirimido. |
WO2005103288A1 (ja) * | 2004-04-27 | 2005-11-03 | Takeda Pharmaceutical Company Limited | スクリーニング方法 |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
WO2006024486A2 (en) | 2004-08-31 | 2006-03-09 | F. Hoffmann-La Roche Ag | Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
US7494993B2 (en) | 2004-08-31 | 2009-02-24 | Hoffmann-La Roche Inc. | Amide derivatives of 7-amino-3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
CN101374840B (zh) | 2006-01-31 | 2011-09-28 | 霍夫曼-拉罗奇有限公司 | 7h-吡啶并[3,4-d]嘧啶-8-酮、它们的制备及作为蛋白激酶抑制剂的应用 |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
EP2108641A1 (en) * | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
CN107383009B (zh) | 2012-06-13 | 2020-06-09 | 因塞特控股公司 | 作为fgfr抑制剂的取代的三环化合物 |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
BR112015022191A8 (pt) | 2013-03-15 | 2018-01-23 | Celgene Avilomics Res Inc | compostos heteroarila e usos dos mesmos |
ES2892423T3 (es) | 2013-03-15 | 2022-02-04 | Celgene Car Llc | Compuestos de heteroarilo y usos de los mismos |
TWI647220B (zh) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | 雜芳基化合物及其用途 |
CN105263931B (zh) | 2013-04-19 | 2019-01-25 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
EP3617205B1 (en) | 2015-02-20 | 2021-08-04 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
US11479770B2 (en) | 2017-10-05 | 2022-10-25 | Fulcrum Therapeutics, Inc. | Use of p38 inhibitors to reduce expression of DUX4 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
US11466004B2 (en) | 2018-05-04 | 2022-10-11 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
JP2021523118A (ja) | 2018-05-04 | 2021-09-02 | インサイト・コーポレイションIncyte Corporation | Fgfr阻害剤の塩 |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
AU2020366006A1 (en) | 2019-10-14 | 2022-04-21 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
GB201915828D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
BR112022010664A2 (pt) | 2019-12-04 | 2022-08-16 | Incyte Corp | Derivados de um inibidor de fgfr |
EP4069696A1 (en) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
JP2024522189A (ja) | 2021-06-09 | 2024-06-11 | インサイト・コーポレイション | Fgfr阻害剤としての三環式ヘテロ環 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8814352D0 (en) | 1988-06-16 | 1988-07-20 | Smith Kline French Lab | Chemical compounds |
IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
NZ503685A (en) * | 1997-10-20 | 2002-05-31 | F | Fused pyrrole compounds as kinase inhibitors |
DE69939168D1 (de) * | 1998-05-26 | 2008-09-04 | Warner Lambert Co | Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung |
ES2228123T3 (es) | 1998-10-23 | 2005-04-01 | F. Hoffmann-La Roche Ag | Heterociclos de nitrogeno biciclicos. |
-
2000
- 2000-10-13 KR KR10-2002-7005056A patent/KR100537241B1/ko not_active IP Right Cessation
- 2000-10-13 PL PL00357494A patent/PL357494A1/xx not_active Application Discontinuation
- 2000-10-13 WO PCT/EP2000/010077 patent/WO2001029041A1/en not_active Application Discontinuation
- 2000-10-13 AT AT00972755T patent/ATE349447T1/de not_active IP Right Cessation
- 2000-10-13 EP EP00972755A patent/EP1226144B1/en not_active Expired - Lifetime
- 2000-10-13 CN CNB00814544XA patent/CN1156477C/zh not_active Expired - Fee Related
- 2000-10-13 AU AU11375/01A patent/AU776695B2/en not_active Ceased
- 2000-10-13 IL IL14923000A patent/IL149230A0/xx unknown
- 2000-10-13 BR BR0014973-0A patent/BR0014973A/pt not_active IP Right Cessation
- 2000-10-13 CA CA002388140A patent/CA2388140C/en not_active Expired - Fee Related
- 2000-10-13 HU HU0203477A patent/HUP0203477A3/hu unknown
- 2000-10-13 DE DE60032623T patent/DE60032623T2/de not_active Expired - Fee Related
- 2000-10-13 MX MXPA02003841A patent/MXPA02003841A/es active IP Right Grant
- 2000-10-13 YU YU29202A patent/YU29202A/sh unknown
- 2000-10-13 TR TR2002/01058T patent/TR200201058T2/xx unknown
- 2000-10-13 ES ES00972755T patent/ES2277858T3/es not_active Expired - Lifetime
- 2000-10-13 CZ CZ20021743A patent/CZ20021743A3/cs unknown
- 2000-10-17 PE PE2000001106A patent/PE20010760A1/es not_active Application Discontinuation
- 2000-10-19 CO CO00079670A patent/CO5251408A1/es not_active Application Discontinuation
- 2000-10-20 US US09/693,364 patent/US6642241B1/en not_active Expired - Fee Related
- 2000-10-20 AR ARP000105524A patent/AR026187A1/es not_active Application Discontinuation
-
2002
- 2002-04-12 HR HR20020327A patent/HRP20020327A2/hr not_active Application Discontinuation
- 2002-04-16 NO NO20021783A patent/NO20021783L/no not_active Application Discontinuation
- 2002-04-19 MA MA26611A patent/MA26836A1/fr unknown
-
2003
- 2003-05-06 HK HK03103209A patent/HK1051040A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20021783D0 (no) | 2002-04-16 |
WO2001029041A1 (en) | 2001-04-26 |
JP4028236B2 (ja) | 2007-12-26 |
JP2003512377A (ja) | 2003-04-02 |
MA26836A1 (fr) | 2004-12-20 |
ATE349447T1 (de) | 2007-01-15 |
AU776695B2 (en) | 2004-09-16 |
HRP20020327A2 (en) | 2004-02-29 |
US6642241B1 (en) | 2003-11-04 |
HUP0203477A3 (en) | 2004-12-28 |
YU29202A (sh) | 2004-12-31 |
EP1226144A1 (en) | 2002-07-31 |
ES2277858T3 (es) | 2007-08-01 |
TR200201058T2 (tr) | 2002-07-22 |
CN1382142A (zh) | 2002-11-27 |
KR100537241B1 (ko) | 2005-12-19 |
AR026187A1 (es) | 2003-01-29 |
EP1226144B1 (en) | 2006-12-27 |
CO5251408A1 (es) | 2003-02-28 |
HK1051040A1 (en) | 2003-07-18 |
CN1156477C (zh) | 2004-07-07 |
PE20010760A1 (es) | 2001-07-21 |
BR0014973A (pt) | 2002-07-16 |
MXPA02003841A (es) | 2002-09-30 |
IL149230A0 (en) | 2002-11-10 |
CZ20021743A3 (cs) | 2002-08-14 |
DE60032623D1 (de) | 2007-02-08 |
NO20021783L (no) | 2002-04-16 |
PL357494A1 (en) | 2004-07-26 |
AU1137501A (en) | 2001-04-30 |
DE60032623T2 (de) | 2007-10-11 |
CA2388140A1 (en) | 2001-04-26 |
KR20020039375A (ko) | 2002-05-25 |
CA2388140C (en) | 2008-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203477A2 (hu) | Alkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállítási eljárásaik | |
HUP9902414A2 (hu) | 2,6,9-triszubsztituált purin-származékok, mint ciklin-függő kináz-2 és -IkB-alfa purin-inhibitorok, valamint ezeket tartalmazó gyógyszerkészítmények | |
HUP0203564A2 (hu) | Heteroalkil-amino-helyettesített biciklikus nitrogén-heterociklusok mint P38 protein-kináz-inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0303458A2 (hu) | 6-Helyettesített pirido-pirimidinek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE71625T1 (de) | Imidazoheterocyclische verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
HUP0303391A2 (hu) | Alifás, nitrogéntartalmú 5-tagú gyűrűs vegyületek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE164575T1 (de) | Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer | |
HUP0303146A2 (hu) | Protein kináz gátló hatású 3-(4-amido-pirrol-2-il-metilidén)-2-indolinon származékok és ezeket tartalmazó gyógyszerkészítmények | |
HUP0100601A2 (hu) | N-tartalmú biciklusos vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0004531A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló 4-aminofenilalanin-vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
HUP0001507A2 (hu) | Pirrolo [2,3-d] pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
GEP20063784B (en) | Optical Resolution of (1-Benzyl-4- Methylpiperidin-3-Yl) -Methylamine Enantiomers and Use Thereof for Preparation of Pyrrolo 2,3-Pyrimidine Derivatives as Protein Kinases Inhibitors | |
HUP9800813A2 (hu) | Laktám-tartalmú hidroxámsav-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0004259A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények | |
MY144655A (en) | Pyrimidine urea derivatives as kinase inhibitors | |
PL1678166T3 (pl) | Inhibitory kinaz białkowych | |
MY136174A (en) | Phosphonooxy quinazoline derivatives and their pharmaceutical use | |
BG104960A (en) | Bicyclic pirimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation | |
HUP9900028A2 (hu) | Gyógyászatilag hatásos kinazolinszármazékok, előállításuk, alkalmazásuk és azokat tartalmazó gyógyszerkészítmények | |
CY2413B1 (en) | Protein kinase C inhibitors. | |
CY1107422T1 (el) | Φουραζανοβενζιμιδαζoλες | |
EP0852499A4 (en) | AZID COMPOUNDS FOR THERAPEUTIC USE | |
NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
HUP0301032A2 (hu) | Ciklin-dependens kinázok N-{5-[(5-alkil-2-oxazolil)-metil-tio]-2-tiazolil}-karboxamid inhibitorai, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
ATE291018T1 (de) | Pyrazol verbindungen und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |